Heart Failure Diagnostic Tech to Be Shown in Phoenix
Clinicians will review new blood volume analysis technology at the Heart Failure Society of America meeting.
Updated on Oct. 1, 2026 in Heart Disease
Live Poll
Do you believe new medical diagnostic technologies generally improve patient outcomes in hospital settings?
New diagnostic technology will be showcased at the Heart Failure Society of America Annual Scientific Meeting held in Phoenix from October 9-12, 2026. Independent researchers will present clinical data on the Blood Volume Analyzer platform during the conference.
Why it matters
Accurate assessment of blood volume is critical for managing heart failure patients, and advancements in diagnostic speed and sample requirements can improve clinical workflows. The upcoming presentations will offer hospital administrators and clinicians a look at updated diagnostic capabilities.
Independent investigators will present two ePosters on October 10, 2026, featuring a diagnostic platform that achieves over 95% measurement accuracy. The system requires 50% less blood volume and operates 3x faster than the predecessor BVA-100 platform.
The players
Daxor Corporation
A developer of diagnostic platforms and blood volume analysis technologies focused on heart failure management.
Heart Failure Society of America
A professional society dedicated to the advancement of heart failure research and clinical care standards.
The details
The Blood Volume Analyzer provides precise data on total blood volume, which is vital for guiding fluid management in patients with complex heart failure. The next-generation system utilizes updated processing to achieve faster results and minimize the blood needed for diagnostics, helping to streamline assessment protocols in busy clinical settings.
Timeline
October 9-12, 2026: The HFSA Annual Scientific Meeting takes place in Phoenix.
October 10, 2026: Independent researchers will present two ePosters featuring the diagnostic platform.
Health Landscape
This development occurs within the context of the Heart Failure Society of America Annual Scientific Meeting, a key forum for disseminating new clinical evidence. The platform’s exhibition underscores a broader trend of prioritizing faster, minimally invasive diagnostics in heart failure care.
While this news focuses on professional diagnostic tools, patients with heart failure should discuss which monitoring technologies their care team uses to manage their fluid status. Ask your cardiologist about the diagnostic methods used to track your blood volume and how those results influence your treatment.
The takeaway
Advancements in diagnostic technology continue to prioritize smaller blood samples and faster processing to aid clinical decision-making. Patients should always consult with their physician to understand how specific diagnostic assessments are being utilized in their individual heart failure care plan.
What happens next
Independent researchers will present their findings regarding the diagnostic platform at scheduled monitor sessions on October 10, 2026.
Further reading
Learn more about the latest innovations in Heart Disease management.
Source note: This article includes information reported by The Manila times.
Live Poll
Do you believe new medical diagnostic technologies generally improve patient outcomes in hospital settings?
